methazolamide has been researched along with pyruvic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrikopoulos, S; Connor, T; Cooper, A; de Vries, M; Fahey, R; Foletta, VC; Garcia-Guerra, L; Jones, S; Konstantopoulos, N; Krippner, G; McGee, SL; Molero, JC; Morrison, S; Spolding, B; Swinton, C; Walder, KR; Wanyonyi, S | 1 |
1 other study(ies) available for methazolamide and pyruvic acid
Article | Year |
---|---|
Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo.
Topics: Animals; Blood Glucose; Carbonic Anhydrase Inhibitors; Diabetes Mellitus, Experimental; Glucose Clamp Technique; Glucose-6-Phosphatase; Glycolysis; Homeostasis; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Metformin; Methazolamide; Mice; Mice, Inbred C57BL; Mice, Obese; Oxygen Consumption; Phosphoenolpyruvate Carboxykinase (ATP); Pyruvic Acid; Rats; Rats, Sprague-Dawley | 2012 |